BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16156852)

  • 1. Autologous stem cell transplantation in the treatment of adults with acute myeloid leukaemia.
    Breems DA; Löwenberg B
    Br J Haematol; 2005 Sep; 130(6):825-33. PubMed ID: 16156852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukemia and the position of autologous stem cell transplantation.
    Breems DA; Löwenberg B
    Semin Hematol; 2007 Oct; 44(4):259-66. PubMed ID: 17961725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: a prospective randomized Dutch-Belgian Haemato-Oncology Co-operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial.
    Breems DA; Boogaerts MA; Dekker AW; Van Putten WL; Sonneveld P; Huijgens PC; Van der Lelie J; Vellenga E; Gratwohl A; Verhoef GE; Verdonck LF; Löwenberg B
    Br J Haematol; 2005 Jan; 128(1):59-65. PubMed ID: 15606550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An antecedent diagnosis of refractory anemia with excess blasts has no influence on mobilization of peripheral blood stem cells and hematopoietic recovery after autologous stem cell transplantation in acute myeloid leukemia.
    Viola A; Falco C; D'Elia R; D'Amico MR; Vicari L; Tambaro FP; Correale P; Laudati D; Palmieri S; Ferrara F
    Eur J Haematol; 2007 Jan; 78(1):41-7. PubMed ID: 17042770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia.
    Maurillo L; Buccisano F; Del Principe MI; Del Poeta G; Spagnoli A; Panetta P; Ammatuna E; Neri B; Ottaviani L; Sarlo C; Venditti D; Quaresima M; Cerretti R; Rizzo M; de Fabritiis P; Lo Coco F; Arcese W; Amadori S; Venditti A
    J Clin Oncol; 2008 Oct; 26(30):4944-51. PubMed ID: 18606980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FLT3 mutations in normal karyotype acute myeloid leukemia in first complete remission treated with autologous peripheral blood stem cell transplantation.
    Yoshimoto G; Nagafuji K; Miyamoto T; Kinukawa N; Takase K; Eto T; Kato K; Hayashi S; Kamimura T; Ohno Y; Taniguchi S; Harada M
    Bone Marrow Transplant; 2005 Dec; 36(11):977-83. PubMed ID: 16184177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysis.
    Godder K; Eapen M; Laver JH; Zhang MJ; Camitta BM; Wayne AS; Gale RP; Doyle JJ; Yu LC; Chen AR; Garvin JH; Sandler ES; Yeager AM; Edwards JR; Horowitz MM
    J Clin Oncol; 2004 Sep; 22(18):3798-804. PubMed ID: 15365077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial.
    Ribera JM; Oriol A; Bethencourt C; Parody R; Hernández-Rivas JM; Moreno MJ; del Potro E; Torm M; Rivas C; Besalduch J; Sanz MA; Ortega JJ;
    Haematologica; 2005 Oct; 90(10):1346-56. PubMed ID: 16219571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous stem cell transplantation in acute myeloid leukemia. Factors influencing outcome. A 13 year single institution experience.
    Martins C; Lacerda JF; Lourenço F; Carmo JA; Lacerda JM
    Acta Med Port; 2005; 18(5):329-37. PubMed ID: 16611537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission: a meta-analysis of randomized trials.
    Wang J; Ouyang J; Zhou R; Chen B; Yang Y
    Acta Haematol; 2010; 124(2):61-71. PubMed ID: 20616541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reassessing autotransplantation for acute myeloid leukaemia in first remission - a matched pair analysis of autologous marrow vs peripheral blood stem cells.
    Sirohi B; Powles R; Kulkarni S; Rudin C; Frassoni F; Bacigalupo A; Singhal S; Vaidya S; Labopin M; Michallet M; Blaise D; Reiffers J; Meloni G; Rio B; Treleaven J; Horton C; Mehta J
    Bone Marrow Transplant; 2004 Jun; 33(12):1209-14. PubMed ID: 15094749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous stem cell transplantation for acute myeloid leukemia.
    Linker CA
    Bone Marrow Transplant; 2003 May; 31(9):731-8. PubMed ID: 12732879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of cytogenetics on the outcome of autotransplantation for acute myeloid leukemia in first remission: is the benefit of intensive pretransplant therapy limited to patients with good karyotypes?
    Mehta J; Powles R; Sirohi B; Treleaven J; Swansbury GJ; Kulkarni S; Saso R; Singhal S
    Bone Marrow Transplant; 2003 Jul; 32(2):157-64. PubMed ID: 12838280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous stem cell transplantation in myelodysplastic syndromes.
    de Witte T; Suciu S; Brand R; Muus P; Kröger N
    Semin Hematol; 2007 Oct; 44(4):274-7. PubMed ID: 17961727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell transplantation in acute myelogenous leukemia in first remission: what are the options?
    Mathews V; DiPersio JF
    Curr Hematol Rep; 2004 Jul; 3(4):235-41. PubMed ID: 15217552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloablative chemotherapy followed by autologous stem cell infusion may overcome the adverse prognostic impact of FLT3 (foetal liver tyrosine kinase 3) mutations in patients with acute myeloid leukaemia and normal karyotype.
    Palmieri S; Ferrara F; Leoni F; Ciolli S; Pollio F; D'Amico MR; Celentano M; Viola A; Vicari L; Izzo B; Pane F
    Hematol Oncol; 2007 Mar; 25(1):1-5. PubMed ID: 17036374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous versus allogeneic stem cell transplantation in acute myeloid leukemia.
    Willemze R; Suciu S; Mandelli F; de Witte T; Amador S;
    Ann Hematol; 2004; 83 Suppl 1():S134. PubMed ID: 15124706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of allogeneic stem cell transplantation on outcome in younger acute myeloid leukemia patients with minimal residual disease detected by flow cytometry at the end of post-remission chemotherapy.
    Laane E; Derolf AR; Björklund E; Mazur J; Everaus H; Söderhäll S; Björkholm M; Porwit-MacDonald A
    Haematologica; 2006 Jun; 91(6):833-6. PubMed ID: 16769587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early allogeneic stem-cell transplantation for young adults with acute myeloblastic leukemia in first complete remission: an intent-to-treat long-term analysis of the BGMT experience.
    Jourdan E; Boiron JM; Dastugue N; Vey N; Marit G; Rigal-Huguet F; Molina L; Fegueux N; Pigneux A; Recher C; Rossi JF; Attal M; Sotto JJ; Maraninchi D; Reiffers J; Bardou VJ; Esterni B; Blaise D
    J Clin Oncol; 2005 Oct; 23(30):7676-84. PubMed ID: 16186596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced intensity conditioning prior to allogeneic stem cell transplantation for patients with acute myeloblastic leukemia as a first-line treatment.
    Blaise DP; Michel Boiron J; Faucher C; Mohty M; Bay JO; Bardoux VJ; Perreau V; Coso D; Pigneux A; Vey N
    Cancer; 2005 Nov; 104(9):1931-8. PubMed ID: 16178004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.